Free Access
Issue
Med Sci (Paris)
Volume 28, Number 10, Octobre 2012
Page(s) 845 - 851
Section Récepteurs couplés aux protéines G
DOI https://doi.org/10.1051/medsci/20122810012
Published online 12 October 2012
  1. Monod J, Wyman J, Changeux JP. On the nature of allosteric transitions: a plausible model. J Mol Biol 1965 ; 12 : 88–118. [CrossRef] [PubMed] [Google Scholar]
  2. Changeux JP. Allosteric receptors: from electric organ to cognition. Annu Rev Pharmacol Toxicol 2010 ; 50 : 1–38. [CrossRef] [PubMed] [Google Scholar]
  3. Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there? Nat Rev Drug Discov 2006 ; 5 : 993–996. [CrossRef] [PubMed] [Google Scholar]
  4. Lagerstrom MC, Schioth HB. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 2008 ; 7 : 339–357. [CrossRef] [PubMed] [Google Scholar]
  5. Chung S, Funakoshi T, Civelli O. Orphan GPCR research. Br J Pharmacol 2008 ; 153 : S339–S346. [CrossRef] [PubMed] [Google Scholar]
  6. Hopkins AL, Groom CR. The druggable genome. Nat Rev Drug Discov 2002 ; 1 : 727–730. [CrossRef] [PubMed] [Google Scholar]
  7. Sigel E. Mapping of the benzodiazepine recognition site on GABA(A) receptors. Curr Top Med Chem 2002 ; 2 : 833–839. [CrossRef] [PubMed] [Google Scholar]
  8. Conn PJ, Christopoulos A, Lindsley CW. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nat Rev Drug Discov 2009 ; 8 : 41–54. [CrossRef] [PubMed] [Google Scholar]
  9. May LT, Leach K, Sexton PM, Christopoulos A. Allosteric modulation of G protein-coupled receptors. Annu Rev Pharmacol Toxicol 2007 ; 47 : 1–51. [CrossRef] [PubMed] [Google Scholar]
  10. Kenakin T, Miller LJ. Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol Rev 2010 ; 62 : 265–304. [CrossRef] [PubMed] [Google Scholar]
  11. Hall DA. Modeling the functional effects of allosteric modulators at pharmacological receptors: an extension of the two-state model of receptor activation. Mol Pharmacol 2000 ; 58 : 1412–1423. [PubMed] [Google Scholar]
  12. Smit MJ, Vischer HF, Bakker RA, et al. Pharmacogenomic and structural analysis of constitutive G protein-coupled receptor activity. Annu Rev Pharmacol Toxicol 2007 ; 47 : 53–87. [CrossRef] [PubMed] [Google Scholar]
  13. Macarron R, Banks MN, Bojanic D, et al. Impact of high-throughput screening in biomedical research. Nat Rev Drug Discov 2011 ; 10 : 188–195. [CrossRef] [PubMed] [Google Scholar]
  14. Emkey R, Rankl NB. Screening G protein-coupled receptors: measurement of intracellular calcium using the fluorometric imaging plate reader. Methods Mol Biol 2009 ; 565 : 145–158. [CrossRef] [PubMed] [Google Scholar]
  15. Pantel J, Williams SY, Mi D, et al. Development of a high throughput screen for allosteric modulators of melanocortin-4 receptor signaling using a real time cAMP assay. Eur J Pharmacol 2011 ; 660 : 139–147. [CrossRef] [PubMed] [Google Scholar]
  16. Hughes JP, Rees S, Kalindjian SB, Philpott KL. Principles of early drug discovery. Br J Pharmacol 2011 ; 162 : 1239–1249. [CrossRef] [PubMed] [Google Scholar]
  17. Zhang JH, Chung TD, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999 ; 4 : 67–73. [CrossRef] [PubMed] [Google Scholar]
  18. Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci 2001 ; 2 : 274–286. [CrossRef] [PubMed] [Google Scholar]
  19. Bockaert J, Perroy J, Becamel C, et al. GPCR interacting proteins (GIP) in the nervous system: roles in physiology and pathologies. Annu Rev Pharmacol Toxicol 2010 ; 50 : 89–109. [CrossRef] [PubMed] [Google Scholar]
  20. Rajagopal S, Rajagopal K, Lefkowitz RJ. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat Rev Drug Discov 2010 ; 9 : 373–386. [CrossRef] [PubMed] [Google Scholar]
  21. Milligan G, Smith NJ. Allosteric modulation of heterodimeric G-protein-coupled receptors. Trends Pharmacol Sci 2007 ; 28 : 615–620. [CrossRef] [PubMed] [Google Scholar]
  22. Swinney DC, Anthony J. How were new medicines discovered? Nat Rev Drug Discov 2011 ; 10 : 507–519. [CrossRef] [PubMed] [Google Scholar]
  23. Keov P, Sexton PM, Christopoulos A. Allosteric modulation of G protein-coupled receptors: a pharmacological perspective. Neuropharmacology 2011 ; 60 : 24–35. [CrossRef] [PubMed] [Google Scholar]
  24. Wood MR, Hopkins CR, Brogan JT, et al. Molecular switches on mGluR allosteric ligands that modulate modes of pharmacology. Biochemistry 2011 ; 50 : 2403–2410. [CrossRef] [PubMed] [Google Scholar]
  25. Harrington PE, Fotsch C. Calcium sensing receptor activators: calcimimetics. Curr Med Chem 2007 ; 14 : 3027–3034. [CrossRef] [PubMed] [Google Scholar]
  26. Dorr P, Westby M, Dobbs S, et al. Maraviroc (UK-427, 857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob Agents Chemother 2005 ; 49 : 4721–4732. [CrossRef] [PubMed] [Google Scholar]
  27. Urwyler S. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives. Pharmacol Rev 2011 ; 63 : 59–126. [CrossRef] [PubMed] [Google Scholar]
  28. Ollmann MM, Wilson BD, Yang YK, et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997 ; 278 : 135–138. [CrossRef] [PubMed] [Google Scholar]
  29. Massot O, Rousselle JC, Fillion MP, et al. 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors. Mol Pharmacol 1996 ; 50 : 752–762. [PubMed] [Google Scholar]
  30. Lazareno S, Dolezal V, Popham A, Birdsall NJ. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity. Mol Pharmacol 2004 ; 65 : 257–266. [CrossRef] [PubMed] [Google Scholar]
  31. Jockers R, Gbahou F, Kamal M, Tadagaki K. Oligomérisation des protéines humaines et virales à 7 domaines transmembranaires : nouvelle stratégie virale pour manipuler la cellule hôte. Med Sci (Paris) 2012 ; 28 : 864–869. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  32. Galès C. Plasticité des récepteurs couplés aux protéines G et signalisation : un Rubik's cube. Med Sci (Paris) 2012 ; 28 : 883–885. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.